APMD vs ATTO: fair value comparison
Apnimed, Inc. and Attovia Therapeutics, Inc. · Updated 2026-10-19
APMD has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. ATTO has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, APMD currently ranks higher by quality score.
| APMD | ATTO | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $17.76 | $13.73 |
| 12-month range | $17.76–$26.85 | $13.73–$22.22 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #176 of 301 Healthcare | #177 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Low |
| RSI zone | Oversold | Oversold |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: APMD fair value analysis · ATTO fair value analysis